11 – 20 of 139
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
- 2020
-
Mark
Functional Role of Glycosaminoglycans in Decellularized Lung Extracellular Matrix
(
- Contribution to journal › Article
-
Mark
Hypercapnia in advanced chronic obstructive pulmonary disease : A secondary analysis of the national emphysema treatment trial
(
- Contribution to journal › Article
-
Mark
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators : an analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Reduced variability of endurance time in new protocols for exercise tests in COPD
(
- Contribution to journal › Article
-
Mark
The Swedish National Airway Register (SNAR) : development, design and utility to date
(
- Contribution to journal › Article
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
(
- Contribution to journal › Article
-
Mark
A new maximal bicycle test using a prediction algorithm developed from four large COPD studies
(
- Contribution to journal › Article
-
Mark
Clinical characteristics of the BREATHE cohort–a real-life study on patients with asthma and COPD
(
- Contribution to journal › Article